CARDIAC PROSTHETIC MARKET SIZE TO REACH USD 19 BILLION BY 2025, GROWING AT A CAGR OF 14% DURING THE FORECAST PERIOD

Cardiac Prosthetic Devices Market Size, Share, Trends, Analysis Report by Products (Cardiac Pacemakers and Heart Valve Replacement Devices) End-Users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgical Centers), and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2020–2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

305 Pages

icon-table

46 Tables

icon-chart

161 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

18 Companies

icon-market

3 Market Segment

CARDIAC PROSTHETIC DEVICES MARKET REPORT SCOPE

Report Attribute Details
Market Size (Revenue) USD 19 Billion (2025)
CAGR 14% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Products (Cardiac Pacemakers and Heart Valve Replacement Devices) End-Users (Hospitals, Specialty Cardiac Centers, and Ambulatory Surgical Centers)
Geographic Analysis APAC, Europe, North America, Latin America, and Middle East & Africa
Countries Covered Spain, Germany, Italy, France, UK, US, Canada, South Korea, China, Japan, Australia, India, Brazil, Argentina, Mexico, Turkey, Saudi Arabia, South Africa

INDUSTRY INSIGHTS

 

The global cardiac prosthetic devices market size will be valued at USD 19 billion in 2025 and is expected to grow at a significant rate during the forecast period. The growing incidence of arrhythmia caused by arterial fibrillation (AF), structural heart diseases, especially heart valve diseases worldwide, is the major factor contributing to the growth. As the occurrence of AF in the general population in developed countries is between 1.5% and 3%, and in the elderly population around 20%, the market is likely to increase its market share considerably. Moreover, the prevalence of several valvular disorders such as aortic stenosis (AS), mitral regurgitation, pulmonary stenosis, tricuspid regurgitation, and congenital heart defects has increased at a significant rate over the past few years globally.

The demand for transcatheter valve replacement techniques is growing at a phenomenal rate due to the growing awareness of the devices, favorable reimbursement coverage, and increased prevalence of high-risk patients. The increasing mortality rate due to severe heart valve diseases, especially in the elderly population, is a key global concern among healthcare providers. Therefore, to address this concern, medical practitioners prefer to perform heart valve replacement surgeries with transcatheter technique among high-risk patients. Hence, the increase in the target population, coupled with a growing risk of severe heart valve diseases, is expected to increase the demand for transcatheter surgical techniques.

SNIPPETS

  • The demand for implantable cardiac prosthetic devices is expected to witness the highest incremental growth of $10 billion during the forecast period. 
  • Vendors are likely to focus on developing leadless cardiac pacemaker devices as well as transcatheter mitral valve replacement products to increase the effectiveness of these products. 
  • The demand for technically advanced prosthetics devices is likely to be increased at a significant rate in the coming years worldwide due to the continuous focus on technological advances and improvements, which include MRI-conditional pacemakers and transcatheter replacement devices.
  • While North America, especially the US, is likely to dominate the cardiac prosthetic devices market during the forecast period, APAC is expected to grow at the fastest rate. 

CARDIAC PROSTHETIC DEVICES MARKET SEGMENTATION

This research report includes a detailed segmentation by

  1. Products
  2. End-user
  3. Geography

INSIGHTS BY PRODUCTS

The heart valve replacement devices market is growing at a healthy rate. An increase in the aging population and the presence of a large pool of patients with heart valve diseases is a major factor in driving the segment growth. The market is expected to grow significantly in the coming years due to the growing demand for transcatheter heart valve replacement procedures, especially TAVR, and the availability of next-generation cardiac prosthetic valves.

The growth of the transcatheter heart valves can mainly be attributed to superior safety and efficacy features, coupled with the growing prevalence of heart valve diseases globally. The penetration is high in developed countries such as the US, Germany, Japan, France, the UK, Italy, and Spain.  Similarly, advances in heart valve repair & replacement technologies have helped to boost unit sales of tissue heart valves as the improvement in tissue valves has increased durability, which makes them suitable for implantation in young patients. However, the share of mitral tissue valve replacement procedures is expected to increase during the forecast period as end-users are opting for TAVR heart procedures over aortic tissue valve replacement procedures. The mechanical heart valves segment is likely to account for a slower rate than the tissue and transcatheter heart valves segments. The demand for mechanical heart valves is declining, especially in developed economies, due to high risks and complications of cardiac prosthetic devices and the rapid evolution of advanced tissue and transcatheter heart valves with higher safety and efficacy. However, the global mechanical heart valves market is growing due to a steady increase in demand for mechanical heart valves in developing and emerging countries as these devices are relatively less expensive and offer long-life expectancy.

Advances in technology are improving the safety and efficacy of pacemakers. The conventional cardiac pacemaker segment is growing at a healthy rate due to the high uptake of technologically advanced implantable pacemakers, such as leadless and MRI compatible pacemakers. CRT-P device enhances the heart’s effectiveness and increases the blood flow compared to standard pacemakers. They also improve heart failure symptoms such as shortness of breath, fatigue, and exercise intolerance. CRT-P is an advanced type of pacemaker that provides certain additional advantages such as sensing of heart rate and delivering shock accurately.

Moreover, another prime function of the CRT-P device is to minimize the future chances of heart failure. Hence, the adoption of CRT-Ps is increasing at a significant rate. Besides, favorable public and private reimbursement coverage across the globe is projected to boost the adoption of CRT-Ps, resulting in the overall growth of the global cardiac pacemaker market.

INSIGHTS BY END-USERS

Hospitals are the major end-users for the cardiac prosthetic devices market as they perform a high number of implantation procedures. The increasing number of heart ailments and the growing implantations in the hospitals are fueling the growth of the segment. Healthcare professionals in hospitals use advanced cardiovascular prosthetic devices such as implantable pacemakers, CRT-Ps, transcatheter, tissue, and mechanical heart valves as a treatment procedure of cardiac diseases. The specialty cardiology center segment is expected to grow at an absolute growth of over 140% during the forecast period. The segment is likely to grow at a faster rate than hospitals as they are equipped with better infrastructure for cardiology care. Specialty cardiac centers provide exclusive healthcare services to patients with suspected or diagnosed heart diseases. These centers are solely dedicated to treating patients that are suffering from several ailments such as arrhythmia and structural heart diseases. Ambulatory Surgery Centers (ASC) are growing at a promising rate as they are modern healthcare settings equipped with sophisticated healthcare infrastructure. This segment is expected to witness healthy growth, especially in developed countries, due to the growing popularity of procedures such as pacemaker implants and TAVR over conventional open surgical techniques for implanting cardiac prosthetic heart devices.

INSIGHTS BY GEOGRAPHY

The growth in North America is mainly attributed to the high incidence of cardiac diseases such as heart valve disease and abnormal heart rhythms, the availability of advanced healthcare infrastructure and constant technological innovations, and growing acceptance for transcatheter and other MI procedures. A strong preference for MI procedures is one of the key reasons for high market share. Europe is the second-largest cardiac prosthetic devices market, particularly Western Europe, has a well-established healthcare infrastructure with access to advanced healthcare services, especially for replacement procedures for heart diseases such as arrhythmia and heart valve diseases. Also, the increasing incidence of abnormal heart rhythm, heart valve disease, rapid adoption of advanced cardiac assist devices, and high healthcare expenditures are driving the cardiac prosthetic devices market growth in Europe.

APAC is growing at a significant rate and is expected to grow during the forecast period. The presence of a large pool of patient population, improvements in healthcare infrastructure, and increased healthcare expenditure are the factors contributing to the growth. Further, the increasing prevalence of heart diseases is a key factor driving the cardiac prosthetic devices market shares.

Brazil, Mexico, and Argentina are the major revenue contributors to Latin America. Cardiovascular diseases (CVDs) are the major cause of mortality in the region. The presence of a large pool of the patient population that requires cardiac prosthetic devices, an increase in government initiatives and funding on healthcare, and improvements in healthcare infrastructure are the main factors driving the growth.

Turkey, Saudi Arabia, and South Africa are the major revenue contributors to the MEA region. The MEA cardiac prosthetic devices market is growing due to the presence of a large pool of patients that require heart valve replacement devices, pacemakers, and CRT-Ps, an increase in government initiatives and healthcare funding, and improvements in healthcare infrastructure. Moreover, the market in MEA is expected to grow due to the increase in healthcare spending, improved literacy rates, increasing awareness about healthcare treatments, and a large middle-class population with high spending power.

INSIGHTS BY VENDORS

The global cardiac prosthetic devices market is highly competitive and characterized by the presence of a few key players and a significant number of other prominent players offering a wide range of advanced and innovative devices. The market is witnessing rapid technological advancements and is significantly affected by new product launches. Abbott, BIOTRONIK, Boston Scientific, Edwards Lifesciences, and Medtronic are the major players with dominant shares in the market. The dominant presence of major players is attributable to their strong presence and endorsement for their products due to the availability of abundant clinical data/evidence regarding safety and efficacy.

Key Vendors

  • Medtronic
  • Boston Scientific
  • Abbott
  • Edwards Lifesciences
  • BIOTRONIK

The cardiac prosthetic devices market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

By Products

  • Cardiac Peacemakers
    • Conventional Cardiac Peacemakers
    • Cardiac Resynchronization Therapy Pacemakers (CRT-Ps)
  • Heart Valve Replacement Devices
    • Transcatheter Heart Valves
    • Tissue Heart Valves
    • Mechanical Heart Valve

By End-user

  • Hospitals
  • Specialty Cardiac Centers
  • ASCs

By Geography

  • Europe
    • Spain
    • Germany
    • Italy
    • France
    • UK
  • North America
    • US
    • Canada
  • APAC
    • South Korea
    • China
    • Japan
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

 

Frequently Asked Questions

What is the cardiac prosthetic devices market size and growth rate during the forecast period?

The global cardiac prosthetic devices market size to cross USD 19 billion by 2020, growing at a CAGR of over 14% during the forecast period.

What are the factors driving the growth of global cardiac prosthetic devices market shares?

As the occurrence of AF in the general population in developed countries is between 1.5% and 3%, and in the elderly population around 20%, the market is likely to increase its market share considerably.

What are the factors driving the growth of North America cardiac prosthetic devices market share?

The growth in North America is mainly attributed to the high incidence of cardiac diseases such as heart valve disease and abnormal heart

Who are the leading vendors in the cardiac prosthetic devices market, and what are their market shares?

Medtronic, Boston Scientific, Abbott, Edwards Lifesciences, and BIOTRONIK are the leading vendors in the market.

Download Free Sample

 The cardiac prosthetic devices market is expected to grow at a CAGR of over 14% during the period 2019–2025.

The following factors are likely to contribute to the growth of the cardiac prosthetic devices market during the forecast period:

  • Arrival of Leadless Cardiac Pacemakers
  • High Growth Potential of Transcatheter Mitral Valve Replacement Devices
  • The emergence of Next-generation Heart Valve Replacement Devices
  • Rise in Strategic Acquisitions

 Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the cardiac prosthetic devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Medtronic
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Boston Scientific
  • Abbott
  • Edwards Lifesciences
  • BIOTRONIK

 Other Vendors

  • Braile Biomédica
    • Business Overview
    • Product Offerings
  • Braile Biomédica
  • CryoLife
  • Labcor Laboratórios
  • Lepu Medical
  • Lifetech Scientific
  • LivaNova
  • MicroPort Scientific
  • Meril Life Sciences
  • MEDICO
  • Shree Pacetronix
  • TTK Healthcare
  • VENUS MEDTECH
  • Vitatron

Market Segmentation by Products   

  • Cardiac Peacemakers
    • Conventional Cardiac Peacemakers
    • Cardiac Resynchronization Therapy Peacemakers (CRT-Ps)
  • Heart Valve Replacement Devices
    • Transcatheter Heart Valves
    • Tissue Heart Valves
    • Mechanical Heart Valve

Market Segmentation by End-user   

  • Hospitals
  • Specialty Cardiac Centers
  • ASCs

Market Segmentation by Geography

  • Europe
    • Spain
    • Germany
    • Italy
    • France
    • UK
  • North America
    • US
    • Canada
  • APAC
    • South Korea
    • China
    • Japan
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • MEA
    • Turkey
    • Saudi Arabia
    • South Africa

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Product

4.4.2 Market Segmentation by End-User

4.4.3 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Arrhythmia and Heart Valve Diseases: An Overview

7.1.1 Background

7.1.2 Cardiac Pacemakers

7.1.3 Heart Valve Replacement Devices for Heart Valve Diseases

7.1.4 Cardiac Prosthetic Devices Market Snapshot

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Rising Patient Pool with Arrhythmia & Heart Valve Diseases

8.1.2 Increasing Demand for Transcatheter Heart Valve Replacement Procedures

8.1.3 New Product Approvals/Launches

8.1.4 Technological Advancements

8.2 Market Restraints

8.2.1 High Cost of Cardiac Prosthetic Devices & Implantation

8.2.2 Risks and Complications Associated with Cardiac Prosthetic Devices

8.2.3 Stringent Government Regulations and Product Recalls

8.3 Market Opportunities and Trends

8.3.1 Advent of Leadless Cardiac Pacemakers

8.3.2 High Growth Potential of Transcatheter Mitral Valve Replacement Devices

8.3.3 Promising Investigational Cardiac Prosthetic Devices

8.3.4 Growing Demand for Automated Cardiac Prosthetic Devices Integrated with Remote Monitoring Platforms

8.3.5 Emergence of Next-generation Heart Valve Replacement Devices

8.3.6 Strategic Acquisitions

9 Market Landscape

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Product

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

11 Heart Valve Replacement Devices

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.2.1 Market Size & Forecast

11.3 Product Segmentation

11.4 Transcatheter Heart Valves

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 Tissue Heart Valves

11.5.1 Market Overview

11.5.2 Market Size & Forecast

11.6 Mechanical Heart Valves

11.6.1 Market Overview

11.6.2 Market Size & Forecast

11.7 Geographic Segmentation

11.7.1 North America: Market Size & Forecast

11.7.2 Europe: Market Size & Forecast

11.7.3 APAC: Market Size & Forecast

11.7.4 Latin America: Market Size & Forecast

11.7.5 Middle East & Africa: Market Size & Forecast

12 Cardiac Pacemakers

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.2.1 Market Size & Forecast

12.3 Product Segmentation

12.4 Conventional Cardiac Pacemakers

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.5 Cardiac Resynchronization Therapy Pacemakers (crt-ps)

12.5.1 Market Overview

12.5.2 Market Size & Forecast

12.6 Geographic Segmentation

12.6.1 North America: Market Size & Forecast

12.6.2 Europe: Market Size & Forecast

12.6.3 APAC: Market Size & Forecast

12.6.4 Latin America: Market Size & Forecast

12.6.5 Middle East & Africa: Market Size & Forecast

13 End-User

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Hospitals

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Specialty Cardiac Centers

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.5 ASCs

13.5.1 Market Overview

13.5.2 Market Size & Forecast

14 Geography

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

15 North America

15.1 Market Overview

15.2 Market Size & Forecast

15.3 Key Countries

15.3.1 US: Market Size & Forecast

15.3.2 Canada: Market Size & Forecast

16 Europe

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 Germany: Market Size & Forecast

16.3.2 France: Market Size & Forecast

16.3.3 UK: Market Size & Forecast

16.3.4 Italy: Market Size & Forecast

16.3.5 Spain: Market Size & Forecast

17 APAC

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 Japan: Market Size & Forecast

17.3.2 China: Market Size & Forecast

17.3.3 India: Market Size & Forecast

17.3.4 Australia: Market Size & Forecast

17.3.5 South Korea: Market Size & Forecast

18 Latin America

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Brazil: Market Size & Forecast

18.3.2 Mexico: Market Size & Forecast

18.3.3 Argentina: Market Size & Forecast

19 Middle East & Africa

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Key Countries

19.3.1 Turkey: Market Size & Forecast

19.3.2 Saudi Arabia: Market Size & Forecast

19.3.3 South Africa: Market Size & Forecast

20 Competitive Landscape

20.1 Competition Overview

20.1.1 Medtronic

20.1.2 Boston Scientific

20.1.3 Abbott

20.1.4 Edwards Lifesciences

20.1.5 Biotronik

20.2 Market Share Analysis: Cardiac Pacemakers

20.3 Market Share Analysis: Heart Valve Replacement Devices

21 Key Company Profiles

21.1 Medtronic

21.1.1 Business Overview

21.1.2 Major Product Offerings

21.1.3 Key Strengths

21.1.4 Key Strategies

21.1.5 Key Opportunities

21.2 Boston Scientific

21.2.1 Business Overview

21.2.2 Major Product Offerings

21.2.3 Key Strengths

21.2.4 Key Strategies

21.2.5 Key Opportunities

21.3 Abbott

21.3.1 Business Overview

21.3.2 Major Product Offerings

21.3.3 Key Strengths

21.3.4 Key Strategies

21.3.5 Key Opportunities

21.4 Edwards Lifesciences

21.4.1 Business Overview

21.4.2 Major Product Offerings

21.4.3 Key Strengths

21.4.4 Key Strategies

21.4.5 Key Opportunities

21.5 BIOTRONIK

21.5.1 Business Overview

21.5.2 Major Product Offerings

21.5.3 Key Strengths

21.5.4 Key Strategies

21.5.5 Key Opportunities

22 Other Prominent Vendors

22.1 Braile Biomédica

22.1.1 Business Overview

22.1.2 Key Product Offerings

22.2 CryoLife

22.2.1 Business Overview

22.2.2 Key Product Offerings

22.3 Labcor Laboratórios

22.3.1 Business Overview

22.3.2 Key Product Offerings

22.4 Lepu Medical

22.4.1 Business Overview

22.4.2 Key Product Offerings

22.5 Lifetech Scientific

22.5.1 Business Overview

22.5.2 Key Product Offerings

22.6 LivaNova

22.6.1 Business Overview

22.6.2 Key Product Offerings

22.7 MicroPort Scientific

22.7.1 Business Overview

22.7.2 Key Product Offerings

22.8 Meril Life Sciences

22.8.1 Business Overview

22.8.2 Key Product Offerings

22.9 MEDICO

22.9.1 Business Overview

22.9.2 Key Product Offerings

22.10 Shree Pacetronix

22.10.1 Business Overview

22.10.2 Key Product Offerings

22.11 TTK Healthcare

22.11.1 Business Overview

22.11.2 Key Product Offerings

22.12 VENUS MEDTECH

22.12.1 Business Overview

22.12.2 Key Product Offerings

22.13 Vitatron

22.13.1 Business Overview

22.13.2 Key Product Offerings

23 Report Summary

23.1 Key Takeaways

23.2 Strategic Recommendations

23.3 Quantitative Summary

23.3.1 Product

23.3.2 End-User

23.3.3 Geography

24 Appendix

24.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Cardiac Prosthetic Devices Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Evolution of Cardiac Pacemakers 1950−2016

Exhibit 4               Indications for Permanent Pacemaker Implantation

Exhibit 5               Global Cardiac Prosthetic Devices Market Share by Geography 2019 (%)

Exhibit 6               Global Cardiac Prosthetic Devices Market Share by Product 2019 (%)

Exhibit 7               Impact of Rising Patient Pool with Arrhythmia & Heart Valve Diseases

Exhibit 8               Increasing Age Contributing to the Increasing Prevalence of Abnormal Heartbeats

Exhibit 9               Mortality Rate of Atrial Fibrillation Among Men in Developing & Developed Countries 1990-2015 (Per 100,000 population)

Exhibit 10             Risk Factors Associated with Abnormal Heart Rhythms

Exhibit 11             Age-Adjusted Prevalence of Atrial Fibrillation Among Men & Women in Developing & Developed Countries (Per 100,000 population)

Exhibit 12             Percentage of Patients Diagnosed with Mild, Moderate, and Severe Valve Diseases

Exhibit 13             Prevalence of Valve Diseases in Different Age Groups

Exhibit 14             Prevalence of Aortic Regurgitation in Different Age groups

Exhibit 15             Five Year Survival Rate of Major Life-threatening Disorders

Exhibit 16             Impact of Increasing Demand for Transcatheter Heart Valve Replacement Procedures

Exhibit 17             Impact of New Product Approvals/Launches

Exhibit 18             List of Cardiac Prosthetic Devices Approved/Launched Recently

Exhibit 19             Impact of Technological Advancements

Exhibit 20             Advancements in Pacemaker Technology from 1950 to 2016

Exhibit 21             Evolution of Battery Usage in Cardiac Pacemakers from 1950s to 1970s

Exhibit 22             Impact of High Cost of Cardiac Prosthetic Devices & Implantation

Exhibit 23             Percentage Breakdown of Various Cost Components in Cardiac Pacemaker Implantation

Exhibit 24             Breakdown of Pacemaker Implantation Cost in US ($)

Exhibit 25             Impact of Risks & Complications Associated with Cardiac Prosthetic Devices

Exhibit 26             Most Common Cardiac Pacemaker Complications

Exhibit 27             Comparison of Major & Minor Complications Post Cardiac Pacemaker Implantation Up to 6 Months Follow-up

Exhibit 28             Major & Minor Complications Associated with Cardiac Pacemaker Implantation

Exhibit 29             Major and Minor Complication Risk percentage for different age group patients

Exhibit 30             Most Common Cardiac Pacemaker Complications

Exhibit 31             Impact of Stringent Government Regulations and Product Recalls

Exhibit 32             “Protecting Patients, Promoting Public Health” Recommends

Exhibit 33             Impact of Advent of Leadless Cardiac Pacemakers

Exhibit 34             Impact of High Growth Potential of Transcatheter Mitral Valve Replacement Devices

Exhibit 35             Impact of Promising Investigational Cardiac Prosthetic Devices

Exhibit 36             Cardiac Prosthetic Pipeline Devices

Exhibit 37             Impact of Growing Demand for Automated Cardiac Prosthetic Devices Integrated with Remote Monitoring Platforms

Exhibit 38             Factors to be Considered for Rhythmic Management (RM) Systems

Exhibit 39             Impact of Emergence of Next-generation Heart Valve Replacement Devices

Exhibit 40             Impact of Strategic Acquisitions

Exhibit 41             Global Cardiac Prosthetic Devices Market 2019−2025 ($ billion)

Exhibit 42             Global Cardiac Prosthetic Devices Market by Geography

Exhibit 43             Global Cardiac Prosthetic Devices Market by Product

Exhibit 44             Global Cardiac Prosthetic Devices Market by End-user

Exhibit 45             Five Force Analysis 2019

Exhibit 46             Incremental Growth by Product 2019 & 2025

Exhibit 47             Global Cardiac Prosthetic Devices Market by Product

Exhibit 48             Incremental Growth by Heart Valve Replacement Devices 2019 & 2025

Exhibit 49             Global Heart Valve Replacement Devices Market 2019−2025 ($ billion)

Exhibit 50             Global Heart Valve Replacement Devices Market by Product

Exhibit 51             Global Heart Valve Replacement Devices Market by Product: Incremental Growth

Exhibit 52             Global Heart Valve Replacement Devices Market by Product: Absolute Growth

Exhibit 53             Global Heart Valve Replacement Devices Market by Product 2019−2025 ($ million)

Exhibit 54             Global Heart Valve Replacement Devices Market by Product 2019−2025 (%)

Exhibit 55             Estimated Number of TAVR Procedure Worldwide 2012−2025

Exhibit 56             Global Transcatheter Heart Valves Market: Incremental & Absolute Growth

Exhibit 57             Global Transcatheter Heart Valves Market 2019−2025 ($ million)

Exhibit 58             Global Tissue Heart Valves Market: Incremental & Absolute Growth

Exhibit 59             Global Tissue Heart Valves Market 2019−2025 ($ million)

Exhibit 60             Global Mechanical Heart Valves Market 2019−2025 ($ million)

Exhibit 61             North America Heart Valve Replacement Devices Market 2019−2025 ($ million)

Exhibit 62             Europe Heart Valve Replacement Devices Market 2019−2025 ($ million)

Exhibit 63             APAC Heart Valve Replacement Devices Market 2019−2025 ($ million)

Exhibit 64             Latin America Heart Valve Replacement Devices Market 2019−2025 ($ million)

Exhibit 65             Middle East & Africa Heart Valve Replacement Devices Market 2019−2025 ($ million)

Exhibit 66             Incremental Growth by Cardiac Pacemakers 2019 & 2025

Exhibit 67             Global Cardiac Pacemakers Market 2019−2025 ($ billion)

Exhibit 68             Global Cardiac Pacemakers Market by Product

Exhibit 69             Global Cardiac Pacemakers Market by Product: Incremental Growth

Exhibit 70             Global Cardiac Pacemakers Market by Product: Absolute Growth

Exhibit 71             Global Cardiac Pacemakers Market by Product 2019−2025 ($ million)

Exhibit 72             Global Cardiac Pacemakers Market by Product 2019−2025 (%)

Exhibit 73             Global Conventional Cardiac Pacemakers Market: Incremental & Absolute Growth

Exhibit 74             Global Conventional Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 75             Global CRT-Ps Market: Incremental & Absolute Growth

Exhibit 76             Global CRT-Ps Market 2019−2025 ($ million)

Exhibit 77             North America Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 78             Europe Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 79             APAC Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 80             Latin America Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 81             Middle East & Africa Cardiac Pacemakers Market 2019−2025 ($ million)

Exhibit 82             Incremental Growth by End-user 2019 & 2025

Exhibit 83             Global Cardiac Prosthetic Devices Market by End-user

Exhibit 84             Global Cardiac Prosthetic Devices Market by End-user: Incremental Growth

Exhibit 85             Global Cardiac Prosthetic Devices Market by End-user: Absolute Growth

Exhibit 86             Global Cardiac Prosthetic Devices Market by End-User 2019−2025 ($ million)

Exhibit 87             Global Cardiac Prosthetic Devices Market by End-User 2019−2025 (%)

Exhibit 88             Global Cardiac Prosthetic Devices Market by Hospitals: Incremental & Absolute Growth

Exhibit 89             Global Cardiac Prosthetic Devices Market by Hospitals 2019−2025 ($ million)

Exhibit 90             Global Cardiac Prosthetic Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth

Exhibit 91             Global Cardiac Prosthetic Devices Market by Specialty Cardiac Centers 2019−2025 ($ million)

Exhibit 92             Global Cardiac Prosthetic Devices Market by ASCs: Incremental & Absolute Growth

Exhibit 93             Global Cardiac Prosthetic Devices Market by ASCs 2019−2025 ($ million)

Exhibit 94             Incremental Growth by Geography 2019 & 2025

Exhibit 95             Global Cardiac Prosthetic Devices Market by Geography

Exhibit 96             Global Cardiac Prosthetic Devices Market by Geography 2019: Key Countries ($ million)

Exhibit 97             Global Cardiac Prosthetic Devices Market by Geography: Incremental Growth

Exhibit 98             Global Cardiac Prosthetic Devices Market by Geography: Absolute Growth

Exhibit 99             Global Cardiac Prosthetic Devices Market by Geography 2019−2025 ($ million)

Exhibit 100          Global Cardiac Prosthetic Devices Market by Geography 2019−2025 (%)

Exhibit 101          Global Cardiac Prosthetic Devices Market in North America in 2019

Exhibit 102          North America Cardiac Prosthetic Devices Market: Absolute & Incremental Growth

Exhibit 103          Cardiac Prosthetic Devices Market in North America 2019–2025 ($ million)

Exhibit 104          Incremental Growth in North America 2019 & 2025

Exhibit 105          Cardiac Prosthetic Devices Market in US 2019–2025 ($ million)

Exhibit 106          Cardiac Prosthetic Devices Market in Canada 2019–2025 ($ million)

Exhibit 107          European Country Wise Pacemaker Implanted Per Million Inhabitants 2009−2013

Exhibit 108          Cardiac Prosthetic Devices Market in Europe 2019

Exhibit 109          Cardiac Prosthetic Devices Market in Europe: Incremental & Absolute Growth

Exhibit 110          Cardiac Prosthetic Devices Market in Europe 2019–2025 ($ million)

Exhibit 111          Absolute Number of Pacemaker Implantation Centers in EU 2013

Exhibit 112          Incremental Growth in Europe 2019 & 2025

Exhibit 113          Cardiac Prosthetic Devices Market in Germany 2019–2025 ($ million)

Exhibit 114          Cardiac Prosthetic Devices Market in France 2019–2025 ($ million)

Exhibit 115          Cardiac Prosthetic Devices Market in UK 2019–2025 ($ million)

Exhibit 116          Cardiac Prosthetic Devices Market in Italy 2019–2025 ($ million)

Exhibit 117          Distribution of Insurance Modality (%)

Exhibit 118          Cardiac Prosthetic Devices Market in Spain 2019–2025 ($ million)

Exhibit 119          APAC Cardiac Prosthetic Devices Market in 2019

Exhibit 120          APAC Cardiac Prosthetic Devices Market: Incremental & Absolute Growth

Exhibit 121          Payment by Governments for Cardiac Pacemakers Implantation in Various APAC Countries (%)

Exhibit 122          Cardiac Prosthetic Devices Market in APAC 2019–2025 ($ million)

Exhibit 123          Incremental Growth in APAC 2019 & 2025

Exhibit 124          Cardiac Prosthetic Devices Market in Japan 2019–2025 ($ million)

Exhibit 125          Provincial Reimbursement Policy in China

Exhibit 126          Cardiac Prosthetic Devices Market in China 2019–2025 ($ million)

Exhibit 127          Cost Comparison of Cardiac Pacemakers in India & US ($)

Exhibit 128          Cardiac Prosthetic Devices Market in India 2019–2025 ($ million)

Exhibit 129          Cardiac Prosthetic Devices Market in Australia 2019–2025 ($ million)

Exhibit 130          Cardiac Prosthetic Devices Market in South Korea 2019–2025 ($ million)

Exhibit 131          Latin America Cardiac Prosthetic Devices Market 2019

Exhibit 132          Latin America Cardiac Prosthetic Devices Market: Incremental & Absolute Growth

Exhibit 133          Cardiac Prosthetic Devices Market in Latin America 2019–2025 ($ million)

Exhibit 134          Incremental Growth in Latin America 2019 & 2025

Exhibit 135          Number of Implantations Performed in Various Developing Countries Per Million

Exhibit 136          Reimbursement Cost in Brazil ($)

Exhibit 137          Cardiac Prosthetic Devices Market in Brazil 2019–2025 ($ million)

Exhibit 138          Cardiac Prosthetic Devices Market in Mexico 2019–2025 ($ million)

Exhibit 139          Cardiac Prosthetic Devices Market in Argentina 2019–2025 ($ million)

Exhibit 140          Middle East & Africa Cardiac Prosthetic Devices Market in 2019

Exhibit 141          Middle East & Africa Cardiac Prosthetic Devices Market: Incremental & Absolute Growth

Exhibit 142          Sub-Saharan Africa Increasing Cardiac Pacing (%) 2004−2015

Exhibit 143          Cardiac Prosthetic Devices Market in Middle East & Africa 2019–2025 ($ million)

Exhibit 144          Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 145          Cardiac Prosthetic Devices Market in Turkey 2019–2025 ($ million)

Exhibit 146          Cardiac Prosthetic Devices Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 147          Cardiac Prosthetic Devices Market in South Africa 2019–2025 ($ million)

Exhibit 148          Global Cardiac Pacemakers Market: Vendors Shares

Exhibit 149          Global Heart Valve Replacement Devices Market: Vendors Shares

Exhibit 150          Medtronic: R&D Expenditure 2017-2019 ($ million)

Exhibit 151          Medtronic: Revenue by Business Segment 2018−2019 ($ million)

Exhibit 152          Medtronic: Revenue by Geography 2019 (%)

Exhibit 153          Boston Scientific: Revenue by Business Segment 2017−2018 ($ million)

Exhibit 154          Boston Scientific R&D Expenditure 2016-2018 ($ million)

Exhibit 155          Boston Scientific: Revenue by Geography 2019 (%)

Exhibit 156          Abbott: Revenue by Business Segment 2017−2018 ($ billion)

Exhibit 157          Abbott: R&D Expenditure 2016−2018 ($ million)

Exhibit 158          Abbott: Revenue by Geography 2018 (%)

Exhibit 159          Edwards Lifesciences: R&D Expenditure 2016−2018 ($ million)

Exhibit 160          Edwards Lifesciences: Revenue by Product Type 2017−2018 ($ million)

Exhibit 161          Edwards Lifesciences: Revenue by Geography 2019 (%)

 

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Comparison of Mechanical & Tissue Heart Valves

Table 4                  Major Transcatheter-based Valve Replacement Devices

Table 5                  Life Span of Few Popular Cardiac Pacemakers

Table 6                  Incidence Rate of Various Complications Post Cardiac Pacemaker Implantation

Table 7                  Major Product Recalls

Table 8                  Comparison of Micra and Nanostim Leadless Cardiac Pacemakers

Table 9                  Major Transcatheter MVR Clinical Trials

Table 10               Recent Acquisitions in Global Cardiac Prosthetic Devices Market

Table 11               Vendors Offering Transcatheter Heart Valves

Table 12               List of Major Tissue Heart Valves

Table 13               List of Major Mechanical Heart Valves

Table 14               Prominent Vendors Offering Implantable Cardiac Pacemakers

Table 15               List of Popular Conventional Cardiac Pacemakers

Table 16               List of Popular CRT-Ps

Table 17               Global Cardiac Pacemakers Market Top Vendors Ranking 2019

Table 18               Global Heart Valve Replacement Devices Top Vendors Ranking 2019

Table 19               Medtronic: Key Product Offerings

Table 20               Boston Scientific: Key Product Offerings

Table 21               Abbott: Product Offerings

Table 22               Edwards Lifesciences: Product Offerings

Table 23               BIOTRONIK: Key Product Offerings

Table 24               Braile Biomédica: Key Product Offerings

Table 25               CryoLife: Key Product Offerings

Table 26               Labcor Laboratórios: Key Product Offerings

Table 27               Lepu Medical: Key Product Offerings

Table 28               Lifetech Scientific: Key Product Offerings

Table 29               LivaNova: Key Product Offerings

Table 30               MicroPort Scientific: Key Product Offerings

Table 31               Meril Life Sciences: Key Product Offerings

Table 32               MEDICO: Key Product Offerings

Table 33               Shree Pacetronix: Key Product Offerings

Table 34               TTK Healthcare: Key Product Offerings

Table 35               VENUS MEDTECH: Key Product Offerings

Table 36               Vitatron: Key Product Offerings

Table 37               Global Cardiac Prosthetic Devices Market by Product ($ million)

Table 38               Global Cardiac Prosthetic Devices Market by Product (%)

Table 39               Global Heart Valve Replacement Devices Market by Product ($ million)

Table 40               Global Heart Valve Replacement Devices Market by Product (%)

Table 41               Global Cardiac Pacemakers Market by Product ($ million)

Table 42               Global Cardiac Pacemakers Market by Product (%)

Table 43               Global Cardiac Prosthetic Devices Market by End-user ($ million)

Table 44               Global Cardiac Prosthetic Devices Market by End-user (%)

Table 45               Global Cardiac Prosthetic Devices Market by Geography ($ million)

Table 46               Global Cardiac Prosthetic Devices Market by Geography (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date